ACRO’s Considerations on Monitoring During COVID-19

On 13 March 2020, ACRO released a list of considerations that support clinical trial monitoring oversight during COVID-19. ACRO recommends that sponsors, clinical research sites, CROs, and technology companies use these emergency interim measures so that clinical trial monitoring is maintained during the current public health crisis. These recommendations will ensure that data quality is unaffected, clinical trial sites are supported, and that the patients enrolled in clinical trials are kept safe.

Considerations to Support Clinical Trial Monitoring Oversight During COVID-19

Scroll to Top